Basel, Switzerland (ots/PRNewswire) - A new study(1) suggests that
treatment with the combination of the innovative cancer drugs Avastin
(bevacizumab) and Tarceva (erlotinib) or Avastin with chemotherapy,
improves progression-free survival in ...

presseportal.de